CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
151
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $49.8K | 0.02% |
1,399
+354
| +34% | +$12.6K |
|
152
PTC Therapeutics
PTCT
$4.51B
| $48.4K | 0.02% |
1,000
+269
| +37% | +$13K |
|
153
Comcast
CMCSA
$125B
| $48.2K | 0.02% |
+1,272
| New | +$48.2K |
|
154
CRISPR Therapeutics
CRSP
$4.75B
| $48.2K | 0.02% |
1,065
-2,533
| -70% | -$115K |
|
155
Netflix
NFLX
$533B
| $46.6K | 0.02% |
+135
| New | +$46.6K |
|
156
ZTO Express
ZTO
$14.6B
| $45.9K | 0.02% |
1,600
| – | – |
|
157
Cytokinetics
CYTK
$5.91B
| $45.1K | 0.02% |
1,282
+321
| +33% | +$11.3K |
|
|
ISEE
158
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $44.8K | 0.02% |
1,843
+616
| +50% | +$15K |
|
159
Intellia Therapeutics
NTLA
$1.23B
| $44.4K | 0.02% |
1,192
+238
| +25% | +$8.87K |
|
160
Denali Therapeutics
DNLI
$2.17B
| $42.6K | 0.01% |
1,851
+471
| +34% | +$10.9K |
|
161
Legend Biotech
LEGN
$6.42B
| $42.3K | 0.01% |
878
+220
| +33% | +$10.6K |
|
162
Amicus Therapeutics
FOLD
$2.43B
| $42.2K | 0.01% |
3,807
+953
| +33% | +$10.6K |
|
163
Vir Biotechnology
VIR
$708M
| $42.1K | 0.01% |
1,809
+456
| +34% | +$10.6K |
|
164
Acadia Pharmaceuticals
ACAD
$4.32B
| $41.4K | 0.01% |
2,198
+553
| +34% | +$10.4K |
|
165
Intel
INTC
$107B
| $40.9K | 0.01% |
+1,251
| New | +$40.9K |
|
166
Vaxcyte
PCVX
$4.06B
| $40.6K | 0.01% |
1,084
+281
| +35% | +$10.5K |
|
|
RETA
167
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $39.6K | 0.01% |
435
+112
| +35% | +$10.2K |
|
|
ABCM
168
DELISTED
Abcam plc American Depositary Shares
ABCM
| $39K | 0.01% |
2,898
+2,583
| +820% | +$34.8K |
|
169
Starbucks
SBUX
$98.6B
| $38.9K | 0.01% |
374
+348
| +1,338% | +$36.2K |
|
170
Honeywell
HON
$136B
| $38.6K | 0.01% |
+202
| New | +$38.6K |
|
171
Ultragenyx Pharmaceutical
RARE
$3.01B
| $38.1K | 0.01% |
951
+239
| +34% | +$9.58K |
|
172
Intuit
INTU
$187B
| $37.9K | 0.01% |
+85
| New | +$37.9K |
|
173
Beam Therapeutics
BEAM
$1.84B
| $37.3K | 0.01% |
1,217
+265
| +28% | +$8.11K |
|
174
Arrowhead Research
ARWR
$3.84B
| $37.3K | 0.01% |
1,467
+390
| +36% | +$9.91K |
|
|
BPMC
175
DELISTED
Blueprint Medicines
BPMC
| $36.6K | 0.01% |
813
+205
| +34% | +$9.22K |
|